AHL Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $2.23M | Buy |
22,624
+9,380
| +71% | +$926K | 0.03% | 688 |
|
|
2017
Q3 | $1.28M | Sell |
13,244
-11,057
| -46% | -$1.06M | 0.02% | 818 |
|
|
2017
Q2 | $2.3M | Buy |
24,301
+3,560
| +17% | +$336K | 0.05% | 583 |
|
|
2017
Q1 | $1.69M | Buy |
20,741
+16,081
| +345% | +$1.31M | 0.04% | 662 |
|
|
2016
Q4 | $395K | Sell |
4,660
-11,683
| -71% | -$990K | 0.01% | 912 |
|
|
2016
Q3 | $1.22M | Buy |
16,343
+1,348
| +9% | +$100K | 0.05% | 537 |
|
|
2016
Q2 | $1.14M | Buy |
14,995
+5,453
| +57% | +$414K | 0.06% | 401 |
|
|
2016
Q1 | $661K | Sell |
9,542
-2,340
| -20% | -$162K | 0.04% | 497 |
|
|
2015
Q4 | $716K | Sell |
11,882
-4,699
| -28% | -$283K | 0.06% | 407 |
|
|
2015
Q3 | $898K | Buy |
16,581
+6,602
| +66% | +$358K | 0.14% | 223 |
|
|
2015
Q2 | $580K | Buy |
9,979
+2,420
| +32% | +$141K | 0.02% | 655 |
|
|
2015
Q1 | $455K | Buy |
7,559
+3,202
| +73% | +$193K | 0.02% | 654 |
|
|
2014
Q4 | $232K | Sell |
4,357
-234
| -5% | -$12.5K | 0.01% | 709 |
|
|
2014
Q3 | $205K | Buy |
+4,591
| New | +$205K | 0.02% | 684 |
|